During the past decade, interest in the so-called systemic collagen diseases,' which are more accurately described as connective tissue diseases, has spread and increased. The present concept of them requires a brief explanation by way of introduction.
It is generally tunderstood that the connective tissues of the body arise from the mesentchyme, and constitute most of the supporting structures which themselves include various serous membranes. Connective tissue varies in composition in different sites, but is usually composed of bundles of fibres (collagenous material) embedded in mucoid ground substance (composed of mucopolysaccharides). Robb Smith (I954) has described the modern concept of disease of collagen but the term was used by Klemperer (I950) to mean all the extra-cellular components of connective tissue. Klemperer held that the term referred to the fact that alterations of the extracellular portions of the connective tissue were prominent and systemic in various diseases. It would seem to embrace, as Banks (I941), among others, has suggested, such hitherto undifferentiated conditions as disseminated lupus erythematosus, polyarteritis nodosa, scleroderma, rheumatic fever and rheumatoid arthritis. Klemperer considered these were related clinically and pathologically, as diffuse vascular and mesenchymal diseases. The typical lesion common to the group is 'fibrinoid change in connective tissue. ' Klinge, in I933, first reported its occurrence in relation to rheumatic fever, believing that its pathogenesis was an allergic tissue reaction, and that fibrinoid degeneration of connective tissue was a characteristic lesion in tissue hypersensitivity. To many observers, there is no doubt that the unifying principle for the systemic collagen diseases is the assumed allergic aetiology of these conditions, and the role of hypersensitivity in human disease is being explored and extended, particularly in relation to. this group of diseases.
The similarity of their histopathology would suggest a common pathogenesis, but a unitary concept for the widely differing clinical manifestations is upheld by some observers, and not accepted by others.
There would, however, appear to be some unity of vascular pathology founded upon an apparently uniform and diffuse arteritis. These diseases often show some common clinical manifestations, viz. fever, polyarthralgia, polyarthritis, anaemia, high sedimentation rate and, to a lesser extent, purpura, a Raynaud phenomenon, polyserositis, renal and pulmonary lesions. Of recent years, the development of steroids has opened the gate to further therapeutic possibilities.
I propose to confine my attention to the pleural and pulmonary lesions, which are fairly common in diffuse collagen disorders, and which have interested me for some years. In such conditions, one encounters changes varying from pleural effusions, partial consolidation, widespread reticulation, miliary mottling to chronic fibrosis and sclero-cystic lung disease ). These lesions must be integrated with the systemic clinical picture which involves the whole of general medicine.
Let us, therefore, first review the pleural and pulmonary lesions of disseminated systemic lupus erythematosus, and illustrate some of them by case records. The natural history of the disease, a review of the literature, the clinical picture of the acute, subacute and more chronic discoid type (with the latter little or no constitutional disorder) have been admirably described by Cohen and Cadman (1953) , who stress the close relationship and gradation between these three types. All interested in the general aspects of this subject are *Being the subject of an opening paper at a meeting of the British 'I'uberculosis Association in London on February 17, I956. Iorld Cohen of Birkenhead was also an opening speaker at this meeting and his paper will be published in a subsequenlt number of this journal. We have encountered these cells in acute pleural, pericardial and synovial effusions (Fig. i) .
In Miall et al. (1953) suggested that the prevalence of rheumatoid arthritis was increased where there was a complicating pneumokoniosis. The question of an association between rheumatoid arthritis and pulmonary tuberculosis was raised by Miall (1955) (Collins, I937) . The interstitial changes at the periphery of the nodules closely resemble those that have been described in the diffuse parenchymal lung lesions (Ellman and Ball, 1948; Christie, 1954 Much support for this viewpoint is obtained from the pathological work of Christie (I954) and is confirmed by Spence (1956) .
A review of the literature on the pulmonary manifestations of rheumatoid disease and a record of cases has been given elsewhere (Ellman, 1947; 
